|1.||Steinbach, Daniel: 2 articles (02/2006 - 12/2003)|
|2.||Sauerbrey, Axel: 2 articles (02/2006 - 12/2003)|
|3.||Zintl, Felix: 2 articles (02/2006 - 12/2003)|
|4.||Gruhn, Bernd: 2 articles (02/2006 - 12/2003)|
|5.||Chang, EunSun: 1 article (05/2015)|
|6.||Ahn, Curie: 1 article (05/2015)|
|7.||Woo, Yu mi: 1 article (05/2015)|
|8.||Kang, Duk-Hee: 1 article (05/2015)|
|9.||Park, Eun Young: 1 article (05/2015)|
|10.||Hwang, Young-Hwan: 1 article (05/2015)|
|1.||Rectal Neoplasms (Rectal Cancer)
10/28/2014 - "This study aimed to clarify the role of multidrug resistance-associated protein 3 (MRP3) in resistance to neoadjuvant chemoradiotherapy and long-term prognosis of advanced rectal cancer. "
10/28/2014 - "Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway."
09/01/2001 - "Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes."
09/01/2001 - "In this study, we show that a multidrug resistance-associated protein 3 (MRP3) is a tumor rejection antigen recognized by HLA-A2402-restricted CTLs established from T cells infiltrating into lung adenocarcinoma. "
|3.||Body Weight (Weight, Body)
10/31/2012 - "Body weight, relative liver weight, biochemical analysis, histopathology, the mRNA and protein expression of Cholesterol 7α-hydroxylase (CYP7A1), farnesoid X receptor (FXR), bile-salt export pump (BSEP), multidrug resistance-associated protein 2 (MRP2), multidrug resistance-associated protein 3 (MRP3) were evaluated to study the EEFP-induced hepatotoxicity and its underlying mechanisms. "
04/01/2001 - "Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver."
02/01/2013 - "Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor."
06/01/2000 - "Because some cholestasis is resulted from altered hepatocyte tight junctions (TJs) or the canalicular multispecific organic anion transporter, we have investigated the following topics in a rat model of inflammatory bowel disease: (1) alterations in hepatocyte TJs and in the canalicular multispecific organic anion transporter, (2) etiologic factors for cholestasis, and (3) effects of antibiotics on cholestasis. "
05/01/2012 - "Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway."
|5.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
|1.||multidrug resistance-associated protein 2
|2.||Messenger RNA (mRNA)
|5.||Adenocarcinoma of lung
|6.||Adenosine Triphosphate (ATP)
|9.||Calcitriol Receptors (Calcitriol Receptor)
|10.||Cytoplasmic and Nuclear Receptors (Nuclear Receptors)